Michael James Elliott's most recent trade in Immunovant Inc was a trade of 342,300 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 19, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunovant Inc | Michael James Elliott | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 342,300 | 342,300 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Michael James Elliott | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 97,600 | 97,600 (0%) | 0% | 0 | Common Stock |